Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
5(33%)
Results Posted
33%(2 trials)

Phase Distribution

Ph phase_1
1
7%
Ph not_applicable
6
40%
Ph phase_3
2
13%
Ph phase_2
6
40%

Phase Distribution

1

Early Stage

6

Mid Stage

2

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
1(6.7%)
Phase 2Efficacy & side effects
6(40.0%)
Phase 3Large-scale testing
2(13.3%)
N/ANon-phased studies
6(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

15

all time

Status Distribution
Active(7)
Completed(6)
Other(2)

Detailed Status

Completed6
Recruiting3
Not yet recruiting2
unknown2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
15
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (6.7%)
Phase 26 (40.0%)
Phase 32 (13.3%)
N/A6 (40.0%)

Trials by Status

not_yet_recruiting213%
unknown213%
recruiting320%
active_not_recruiting213%
completed640%

Recent Activity

5 active trials
Showing 5 of 15
recruitingnot_applicable

Pre-operative Hypofractionated Proton Therapy

NCT05917301
completedphase_2

Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate

NCT00809991
completedphase_2

A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation

NCT02783690
active_not_recruitingnot_applicable

Pre-operative RadiothErapy for Soft Tissue SarcOmas

NCT04617327
active_not_recruitingphase_3

Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate

NCT01444820
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT05917301Not Applicable

Pre-operative Hypofractionated Proton Therapy

Recruiting
NCT00809991Phase 2

Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate

Completed
NCT02783690Phase 2

A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation

Completed
NCT04617327Not Applicable

Pre-operative RadiothErapy for Soft Tissue SarcOmas

Active Not Recruiting
NCT01444820Phase 3

Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate

Active Not Recruiting
NCT03280719Not Applicable

Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions

Completed
NCT04992780Phase 2

Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer

Recruiting
NCT05210270Phase 1

HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy

Not Yet Recruiting
NCT02311049Phase 2

Hypofractionated Radiotherapy for Prostate Cancer

Completed
NCT01921803Phase 2

Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer

Completed
NCT05491395Not Applicable

Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction

Recruiting
NCT05253170Phase 3

Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients

Not Yet Recruiting
NCT04890912Not Applicable

Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II

Unknown
NCT04434677Not Applicable

Hypofractionation And Ultra-Hypofractionation In Adjuvant Radiotherapy For Breast Cancer

Unknown
NCT02460744Phase 2

2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer

Completed

All 15 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
15